마우스에 대한 Surfactin C의 급성경구독성시험

Acute Oral Toxicity of Surfactin C in Mice

  • Park, Byung-Kwon (College of Veterinary Medicine, Chungnam National University) ;
  • Lim, Jong-Hwan (B&C Biopharm) ;
  • Hwang, Youn-Hwan (College of Veterinary Medicine, Chungnam National University) ;
  • Kim, Myung-Seok (College of Veterinary Medicine, Chungnam National University) ;
  • Song, In-Bae (College of Veterinary Medicine, Chungnam National University) ;
  • Lee, Hong-Gee (College of Veterinary Medicine, Chungnam National University) ;
  • Han, Sung-Jin (College of Veterinary Medicine, Chungnam National University) ;
  • Hwang, Mi-Hyun (College of Veternary Medicine, Kyoungbuk National University) ;
  • Kim, Jong-Woo (B&C Biopharm) ;
  • Rhee, Man-Hee (College of Veternary Medicine, Kyoungbuk National University) ;
  • Park, Seong-Chung (College of Veternary Medicine, Kyoungbuk National University) ;
  • Yun, Hyo-In (College of Veterinary Medicine, Chungnam National University)
  • 발행 : 2006.12.30

초록

This study was carried out to investigate the acute toxicity of surfactin C in mice. Surfactin C was administered orally at does of 0, 381, 610, 977, 1562 and 2500 mg/kg. Number of deaths, clinical signs, body weights, feed and water consumptions, and biochemical examinations were investigated for 14 days after single oral administration of surfactin C. $LD_{50}$ value was over 2500mg/kg in mice. In addition, no differences were found between control and treated groups in clinical signs, body weight gains, hematology, serum chemistry, feed and water consumptions. The results indicate that surfactin C did not show any toxic effects at 2500 mg/kg in mice.

키워드

참고문헌

  1. Arima, K., Kakinuma, A. and Tamura, G. (1968): Surfactin, acrystalline peptidelipid surfactant produced by Bacillus subtilis: isolation, characterization and its inhibition of fibrin clot formation. Biochem. Biophys. Res. Commun., 31, 488-494 https://doi.org/10.1016/0006-291X(68)90503-2
  2. Cameotra, S.S. and Makkar, R.S. (2004): Recent applications of biosurfactants as biological and immunological molecules. Curr. Opin. Microbiol., 7, 262-266 https://doi.org/10.1016/j.mib.2004.04.006
  3. Cooper, D.G., Macdonald, C.R., Duff, S.J.B. and Kosaric, N. (1981): Enhanced production of surfactin from Bacillus subtilis by continuous product removal and metal cation additions. Appl. Environ. Microbiol., 42, 408-412
  4. Cooper, D.G., Zajic, J.E. and Gerson, D.F. (1979): Production of surface-active lipids by Corynebacterium lepus. Appl. Environ. Microbiol., 37, 4-10
  5. Desai, J.D. and Banat I.M. (1997): Microbial production of surfactant and their commercial potential. Microbiol. Mol. Biol., 61, 47-64
  6. Hwang, M.H., Lim, J.H., Kim, K.S., Rhee, M.H., Kim, N.W., Kim, J.C. and Park, S.C. (2005a): Antibacterial activity In vitro and primary dermal irritationtest in rabbits of surfactin produced in Bacillus subtilus complex BC2121. J. Toxicol. Pub. Health, 20, 39-43
  7. Hwang, M.H., Lim, J.H., Yun, H.I., Rhee, M.H., Cho, J.Y., Hsu, W.H. and Park, S.C. (2005b): Surfactin C inhibits the lipopolysaccharide-induced transcription of interleukin- 1beta and inducible nitric oxide synthase and nitric oxide production in murine RAW 264.7 cells. Biotechnol Lett., 27, 1605-1608 https://doi.org/10.1007/s10529-005-2515-1
  8. Kameda, Y. Matsui, K., Kato, H., Yamada, T. and Sagai, H. (1972): Antitumor activity of Bacillus natto. 3. Isolation and characterization of a cytolytic substance on Ehrlich ascites carcinoma cells in the culture medium of Bacillus natto KMD 1126. Chem. Pharm. Bull., 20, 1551-1557 https://doi.org/10.1248/cpb.20.1551
  9. Kanatomo, S., Nagai, S., Ohki, K. and Yasuda, Y. (1995): Study on surfactin, a cyclic depsipeptide. I. Isolation and structure of eight surfuctin analogs produced by Bacillus natto KMD 2311. Yakugaku. Zasshi., 115, 756-764 https://doi.org/10.1248/yakushi1947.115.9_756
  10. Kikuchi, T. and Hasumi, K. (2002): Enhancement of plasminogen activation surfactin C: augmentation of fibrinolysis in vitro and in vivo. Biochem. Biophys. Acta., 1596, 234-245
  11. Lim, J.H., Park, B.K., Kim, M.S., Hwang, M.H., Rhee, M.H., Park, S.C, and Yun, H.I. (2005): The anti-thrombotic activity of surfactin. J. Vet. Sci., 6, 353-355
  12. Lim, J.H., Kim, M.S., Park, B.K., Hwang, Y.H., Hwang, M.H., Park, S.C. and Yun, H.I. (2005): Systemic availability and pharmacokinetics of surfactin, a lipopeptide produced by Bacillus subtilis BC1212 in rats. J. Toxicol. Pub. Health, 21, 319-323
  13. Oka, K., Hirano, T., Homma, M., Ishii, H., Murakami, K., Mogami, S., Motizuki, A., Morita, H., Takeya, K. and Itokawa, H. (1993) Satisfactory separation and MS-MS spectrometry of six surfactins isolated from Bacillus subtilis natto. Chem. Pharm. Bull., 41, 1000-1002 https://doi.org/10.1248/cpb.41.1000
  14. Toraya, T., Maoka, T., Tsuji, H. and Kobayashi, H. (1995): Purification and structural determination of an inhibitor of starfish oocyte maturation from a Bacillus species. Appl. Environ. Microbiol., 61, 1799-1804
  15. Tsukagoshi, N., Tamura, G. and Arima, K. (1970): A novel protoplast-bursting factor (surfactin) obtained from bacillus subtilis IAM 1213. II. The interaction of surfactin with bacterial membranes and lipids. Biochim. Biophys. Acta., 196, 211-214 https://doi.org/10.1016/0005-2736(70)90008-8
  16. Vollenbroich, D., Pauli, G., Ozel, M. and Vater, J. (1997): Antimycoplasma properties and application in cell culture of surfactin, a lipopeptide antibiotic from Bacillus subtilis. Appl. Environ. Microbiol., 63, 44-49
  17. Yamashita, K., Nakano, S., Kuwata, M., Yada, H., Irimura, K., Morinaga, H. and Morita, K. (1992): Single dose toxicity studies of suplatast tosilate (IPD-1151T). J. Toxicol. Sci. Jpn., 17, 1-9
  18. Zbinden, G. and Flury-Roversi, M. (1981): Significance of the LD50-test for the toxicological evaluation of chemical substances. Arch. Toxicol., 47, 77-99 https://doi.org/10.1007/BF00332351